Citius Pharmaceuticals reported a GAAP loss of $9.225 million for the first 3 months of fiscal year 2022, up 13.5% from $8.147 million in the prior year.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept